| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/09/2000 | EP1024831A2 Application of tnf antagonists as medicaments for treating septic diseases |
| 08/09/2000 | EP1024829A1 Tolerogenic fragments of natural allergens |
| 08/09/2000 | EP1024828A1 NOVEL pheS (BETA) |
| 08/09/2000 | EP1024823A1 Prevention and treatment of adhesion formation |
| 08/09/2000 | EP1024822A1 Cd8 as an inhibitor of the cellular immune system |
| 08/09/2000 | EP1024821A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 08/09/2000 | EP1024820A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition |
| 08/09/2000 | EP1024816A1 Kits and methods for alleviation of lower gastrointestinal disorders in a human patient |
| 08/09/2000 | EP1024809A1 Use of immunomodulating agents |
| 08/09/2000 | EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 08/09/2000 | EP1024801A2 Method for regulating size and growth of vascularized normal tissue |
| 08/09/2000 | EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 08/09/2000 | EP0786083B1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 08/09/2000 | EP0732915B1 Local delivery of fibrinolysis enhancing agents |
| 08/09/2000 | EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor |
| 08/09/2000 | EP0629238B1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 08/09/2000 | EP0568645B1 Mixed specificity fusion proteins |
| 08/09/2000 | EP0556171B1 Growth hormone antagonists |
| 08/09/2000 | EP0533846B1 The ciliary neurotrophic factor receptor |
| 08/09/2000 | CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same |
| 08/09/2000 | CN1262688A Integrin binding peptide and use thereof |
| 08/09/2000 | CN1262625A Use of lactoferin in treatment of allergen induced disorders |
| 08/09/2000 | CN1262275A Substituted thiazol [3,2-alpha] azatropylidene derivatives |
| 08/09/2000 | CA2327264A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide |
| 08/08/2000 | US6100390 Nucleotide sequences coding nematode protein; for the prevention of nematode infection of animals |
| 08/08/2000 | US6100389 Nucleotide sequences coding protein: for stem cell mobilization, myloid and neuronal cell protection; for the treatment and prevention of tumors and parasitic infection; wound healing agents; antitumor agents |
| 08/08/2000 | US6100387 Chimeric polypeptides containing chemokine domains |
| 08/08/2000 | US6100386 Nucleotide sequences coding polypeptide associated with signal transductionand tyrosine kinases; for the treatment of cancers; anticarcinogenic agents |
| 08/08/2000 | US6100384 Antibodies immunologically specific for a signal mediator protein that induces cellular morphological alterations |
| 08/08/2000 | US6100380 Amino acid sequences; for the treatment of infections, anemias, allergies and immune defects |
| 08/08/2000 | US6100378 Amplification of polypeptide joining to sex cells |
| 08/08/2000 | US6100377 Aromatically adjusted and confined amino acid sequences; for the development of more efficient synthetic polypeptides |
| 08/08/2000 | US6100376 A21, B30, modified insulin derivatives having an altered action profile |
| 08/08/2000 | US6100301 Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists |
| 08/08/2000 | US6100298 Mixture of drug and n-(4-(carboxypropyl)phenyl-4-phenyl-butyramide for improved oral drug delivery |
| 08/08/2000 | US6100296 Modulation of inflammation related to columnar epithelia |
| 08/08/2000 | US6100282 Thiazole derivatives |
| 08/08/2000 | US6100277 Retroviral protease inhibitor combinations |
| 08/08/2000 | US6100249 Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium |
| 08/08/2000 | US6100243 Method of sensitizing tumor cells with adenovirus E1A |
| 08/08/2000 | US6100242 Gene therapies for enhancing cardiac function |
| 08/08/2000 | US6100241 Nucleic acids encoding an immunogenic fragment of eimeria lactate dehydrogenase (ldh) which will react with antiserum raised against the ldh; preparing a vector vaccine against coccidiosis; administering to prevent coccidiosis in birds |
| 08/08/2000 | US6100238 Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors |
| 08/08/2000 | US6100237 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis |
| 08/08/2000 | US6100236 Method and composition for treating thrombosis |
| 08/08/2000 | US6100235 Methods of treating immune and inflammatory response with IL-17 receptors |
| 08/08/2000 | US6100090 Compound 8 to 30 nucleobases in length targeted coding region of human phosphatidyl inositol 3'-kinase p85; therapy and diagnosis of diseases related hormone and growth factor receptors and oncogene products |
| 08/08/2000 | US6100088 Viral vaccines |
| 08/08/2000 | US6100087 Ribozymes targeted to human CCR5 mRNA |
| 08/08/2000 | US6100086 Expression construct of transgene, regulatory sequences, and adenoviral sequences; facilitates persistent expression of transgene in cells and protects cells from cell-mediated immune responses; gene therapy especially for cystic fibrosis |
| 08/08/2000 | US6100085 Isolated, recombinantly-produced 59.5 kilodalton human excitatory amino acid transporter, eaat1; for drug screening of modulators |
| 08/08/2000 | US6100075 Delta 1-pyrroline-5-carboxylate reductase homolog |
| 08/08/2000 | US6100071 Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
| 08/08/2000 | US6100069 Amino acid sequence of peptidyl-propyl cis/trans isomerase involved in protein folding; for screening bacteriostats, bactericides, and antibiotics; diagnosis and prophylaxis |
| 08/08/2000 | US6100067 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes |
| 08/08/2000 | US6100065 Recombinant polypeptide particles with high immunogenicity; comprises portion of pre-s1 peptide and surface antigen peptide |
| 08/08/2000 | US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction |
| 08/08/2000 | US6100059 Compounds |
| 08/08/2000 | US6100055 DNA encoding fα-2m-binding protein and protein encoded thereby |
| 08/08/2000 | US6100054 Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms |
| 08/08/2000 | US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior |
| 08/08/2000 | US6100044 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 08/08/2000 | US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents |
| 08/08/2000 | US6100031 Hybridization assay using specific nucleotide sequence as probe |
| 08/08/2000 | US6099856 Increased bioavailable |
| 08/08/2000 | US6099851 Therapeutic uses of leuprolide acetate |
| 08/08/2000 | US6099844 In human gastrointestinal system; concurrent digestion of plant and enzyme |
| 08/08/2000 | US6099842 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin |
| 08/08/2000 | US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition |
| 08/08/2000 | US6099839 Gonococcal anti-idiotypic antibodies and methods compositions using them |
| 08/08/2000 | US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases |
| 08/08/2000 | US6099837 Pharmaceutical preparation for treating blood coagulation disorders |
| 08/08/2000 | US6099836 Treatment of reperfusion injury |
| 08/08/2000 | US6099835 Method of using antiviral composition |
| 08/08/2000 | US6099832 Transplants for myocardial scars |
| 08/08/2000 | US6099830 Methods for stimulating erythropoiesis using hematopoietic proteins |
| 08/08/2000 | US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/08/2000 | US6099517 Intrapulmonary delivery of polypeptide growth factors and cytokines |
| 08/08/2000 | US6098615 Method of reproducibly effecting a patient's glucose level |
| 08/08/2000 | CA2233144C Arf-p19, a novel regulator of the mammalian cell cycle |
| 08/08/2000 | CA2219795C Modulation of cholesteryl ester transfer protein (cetp) activity |
| 08/08/2000 | CA2216165C Ndf peptides |
| 08/08/2000 | CA2207505C Neurological drug screens |
| 08/08/2000 | CA2157479C Method of treating hepatitis c in non-responders to interferon treatment |
| 08/08/2000 | CA2138270C Prosthetic devices having enhanced osteogenic properties |
| 08/08/2000 | CA2125376C Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof |
| 08/08/2000 | CA2087341C Bone growth stimulator |
| 08/08/2000 | CA2071907C Bcrf1 proteins as inhibitors of interferon-y |
| 08/08/2000 | CA2070664C Antisense oligonucleotide inhibition of papillomavirus |
| 08/08/2000 | CA2011050C Human monocyte-machrophage-csf preparations |
| 08/08/2000 | CA2000893C Biologically active lipoprotein and its use |
| 08/08/2000 | CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function |
| 08/08/2000 | CA1341077C Luminide and macroluminide class of pharmaceuticals |
| 08/08/2000 | CA1341074C Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine |
| 08/08/2000 | CA1341073C Vectors and methods for expression of human protein c activity |
| 08/03/2000 | WO2000045175A1 Urinary trypsin inhibitor to diagnose aids |
| 08/03/2000 | WO2000045167A2 Non-invasive method for detecting target rna |
| 08/03/2000 | WO2000044941A1 A method of treating anemia |
| 08/03/2000 | WO2000044910A1 Methods of use of a novel lysyl oxidase-related protein |
| 08/03/2000 | WO2000044908A2 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |